Harper Cancer Research Institute hosts Walther Cancer Foundation Symposium | News | Notre Dame News | University of Notre Dame Skip To Content Skip To Navigation Skip To Search University of Notre Dame Notre Dame News Experts ND in the News Subscribe About Us Home Contact Search Menu Home › News › Harper Cancer Research Institute hosts Walther Cancer Foundation Symposium Harper Cancer Research Institute hosts Walther Cancer Foundation Symposium Published: February 01, 2018 Author: Brandi Klingerman Walther Cancer Foundation Faculty from the University of Notre Dame will present their research at the Walther Cancer Foundation Symposium Feb. 2-3 (Friday-Saturday). The two-day event is hosted by the Harper Cancer Research Institute (HCRI) and will take place at the Eck Visitors Center. In addition to featuring presentations from a number of Notre Dame researchers, Vadim Backman, professor of biomedical engineering and medicine in hematology/oncology at Northwestern University, will provide the keynote address titled “Convergence of Nanoimaging and Biology: From Decoding Chromatin Packing to Cancer Diagnostics and Therapeutics.” During the address, Backman will discuss how the development of new technologies could help lead to the discovery of anti-cancer therapies and more. In discussing the symposium, M. Sharon Stack, Kleiderer-Pezold Professor of Biochemistry and Ann F. Dunne & Elizabeth Riley Director of the HCRI, said, “Events like the Walther Cancer Foundation Symposium provide an opportunity for researchers to discuss their successes and challenges and establish new collaborations that may be pivotal to discovering solutions for combatting cancer. We are grateful to the Walther Cancer Foundation for providing us this opportunity.” The two-day event will also include presentations by cancer researchers from Indiana University and Purdue University. To view the full symposium schedule, please visit https://harpercancer.nd.edu/news-events/events/2018/02/02/walther-cancer-foundation-symposium/.  Investigators in the HCRI are dedicated to conducting innovative and integrative research that confronts the complex challenges of cancer. From common malignancies to rare and recalcitrant cancers, researchers at Notre Dame and Indiana University School of Medicine-South Bend are united in multi-disciplinary teams with a common goal: to increase the survival of all patients diagnosed with cancer. To learn more, visit harpercancer.nd.edu. Originally published by Brandi Klingerman at research.nd.edu on February 01, 2018. Posted In: Research Home Experts ND in the News Subscribe About Us Related October 05, 2022 Astrophysicists find evidence for the presence of the first stars October 04, 2022 NIH awards $4 million grant to psychologists researching suicide prevention September 29, 2022 Notre Dame, Ukrainian Catholic University launch three new research grants September 27, 2022 Notre Dame, Trinity College Dublin engineers join to advance novel treatment for cystic fibrosis September 22, 2022 Climate-prepared countries are losing ground, latest ND-GAIN index shows For the Media Contact Office of Public Affairs and Communications Notre Dame News 500 Grace Hall Notre Dame, IN 46556 USA Facebook Twitter Instagram YouTube Pinterest © 2022 University of Notre Dame Search Mobile App News Events Visit Accessibility Facebook Twitter Instagram YouTube LinkedIn